ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102051 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102051; 2) Community: the network communities that were significantly associated with the response to NSC 102051; 3) Molecule: the relationships between components within communities and NSC 102051; 4) MDR: the compounds that were significantly associated with the NSC 102051.

NSC Compound Enrichment Correlation
NSC 696559 N-(4-Amino-4-deoxy-N10-methypteroyl)-L-homocysteic acid 0.0219024304994663 0.046107614
NSC 736042 5-chloro-2[(E)-2-(4-nitrophenyl)vinyl]-1H-benzimidazole 0.0219024304994663 0.035383081
NSC 744673 3-PEG FUDR (PEG FLOXURIDINE) 0.0219024304994663 0.32047164
NSC 749028 Null 0.0219024304994663 -0.042394576
NSC 754073 7-(2-methoxybenzyl)-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole 0.0219024304994663 0.036519425
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.024108502230778 0.20061186
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.024108502230778 -0.033664384
NSC 205555 Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- 0.024108502230778 0.030376275
NSC 285233 Null 0.024108502230778 -0.20504667
NSC 295501 Camptothecin Derivative 0.024108502230778 0.23122115
Total:49  Current:21    [First] [Prev] [Next] [Last]